About MEDEVICE
MEDEVICE is a venture capital firm founded in 2011. It is primarily based out of Paris, France. As of Dec 2021, MEDEVICE has invested in 12 companies. It primarily invests in Seed round in France based startups. Its investments are spread across a wide range of sectors from Life Sciences to HealthTech and Enterprise Applications. Most recently it participated in the $***** Seed round of Dyameo Overall, MEDEVICE portfolio has seen 5 acquisitions including key companies like KOELIS, Pixyl and IMACTIS. A lot of funds co-invest with MEDEVICE, with names like BNP Paribas Developpement sharing a substantial percentage of its portfolio. MEDEVICE has team of 1 people including 1 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed & Series A
MEDEVICE's List of Top Investments
MEDEVICE has a portfolio of 12 companies. Their most notable investmentis in DyameoTheir portfolio spans across and France. They have invested in Life Sciences, HealthTech, Enterprise Applications and 2 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by MEDEVICE:1. KOELIS
Developer of MRI/Ultrasound fusion biopsy system for personalized prostate care. The system provides needle guidance, supporting physicians in diagnosis and treatment. The technology tracks the prostate and records core locations, allowing targeted biopsies. It also offers ultrasound platform that compensates for prostate and patient movement.
Key facts about KOELIS
2. Eveon
Manufacture of connected medical devices focused on the preparation and administration of therapeutic treatment. It aims to improve preparation and administration of complex drugs such as lyo, viscous products, suspensions, radiopharmaceuticals, emulsions and cells. The digital platform enables tracking and connected features apart from the core disposable fluidic features. It has developed an Intuity Mix for automated drug preparation, Intuity Spray an airless spray platform for topical medication delivery, and Ad-Mist a fine-mist spray nozzle for precise topical deliveryJect Platfom.
Key facts about Eveon
- Founded Year: 2009
- Location: Montbonnot Saint Martin (France)
- Annual Revenue: €1M - €10M as on Dec 31, 2018
- Stage: Seed
- Total Funding till date: $4.05M
- Employee Count: 11 as on May 31, 2026
- Investors: MEDEVICE, Credit Agricole Alpes Developpement and 1 Other
- Latest Funding Round: Seed, Apr 01, 2010, $*****
- Highlight: Editors' Pick
_1556622634089.png?format=webp&height=120&width=120){kind=logo}
3. Pixyl
Developer of AI tools for neuroimage analysis for clinicians. They offer data-driven patient care services (neuroimage analysis) by analyzing the radiology images for detailed insights on the patient's health condition and treatment plans. They are focused on therapeutic areas including multiple sclerosis, dementia, stroke, and traumatic brain injury. It has features for precision medicine, neuroimaging, reporting, and analysis.
Key facts about Pixyl
4. IMACTIS
Provider of electromagnetic navigation solutions for CT-guided percutaneous procedures. This improves accuracy in reaching targets while avoiding critical structures during interventions. The solution is designed for versatility, working with various percutaneous interventions and integrating seamlessly into existing workflows. It features a quick setup time and a short learning curve, enhancing efficiency for clinicians and hospitals. The system is mobile and compatible with various CT scanners.
Key facts about IMACTIS
- Founded Year: 2009
- Location: La Tronche (France)
- Stage: Acquired
- Total Funding till date: $3.55M
- Employee Count: 9 as on May 31, 2026
- Investors: BNP Paribas Developpement, M Capital and 3 Others
- Latest Funding Round: Series A, Oct 12, 2017, $*****
- Highlight: Acquired
MEDEVICE's Year-on-Year Investment Trends
MEDEVICE has invested in 12 companies over the last 9 years, with an average of 0 new investment annually in the last 5 years. Its most recent first time investment was in Dyameo.MEDEVICE's Investments by Stage
MEDEVICE has made 1 investment in Seed stage with an average round size of $1.13M and 1 investment in Series A stage with an average round size of $3.55M.MEDEVICE's Investments by Sector
MEDEVICE has a diverse portfolio, with companies operating in the Healthcare and Life Sciences. Notably, it has invested in 7 Enterprise (B2B) companies, 7 Tech companies, 4 Software companies and at least 3 companies focusing on Tech hardware.MEDEVICE's Investments by Geography
MEDEVICE has made most investments in France (2).MEDEVICE's recent investments
MEDEVICE has not made any investment in 2026 so far.Here are the most recent investments by MEDEVICE:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Dec 16, 2021 | France | Seed | 1905 | [+1] | |
Oct 12, 2017 | France | Series A | 5326 |
Acquired companies in MEDEVICE's Portfolio
5 companies from MEDEVICE's portfolio have been acquired. The most recent acquisition was Pixyl in Mar 2025 by Gleamer for $*****.Here are MEDEVICE's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 12, 2025 | - | - | 3138 | |
Jan 09, 2023 | Oct 12, 2017 | Series A | 1256 | |
Oct 28, 2021 | - | - | 8943 | |
Sep 17, 2019 | - | - | 1056 | |
Mar 19, 2019 | - | - | 3161 |
_1556622634089.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Team profile of MEDEVICE
MEDEVICE has a team of 1 member located in France. MEDEVICE's team does not sit on the board of any company as of now.Co-investors of MEDEVICE
Over the past 9 years, 6 investors have co-invested in MEDEVICE's portfolio companies. This includes funds and angels.
- Top Co-investors of MEDEVICE: 6 investors entered a company along with MEDEVICE. These include investors like BNP Paribas Developpement (1 company).
Recent News related to MEDEVICE
•
